Identification of novel receptor for bovine leukemia virus via cloning with common B cell epitope
Project/Area Number |
16F16404
|
Research Category |
Grant-in-Aid for JSPS Fellows
|
Allocation Type | Single-year Grants |
Section | 外国 |
Research Field |
Animal production science
|
Research Institution | Institute of Physical and Chemical Research |
Principal Investigator |
間 陽子 国立研究開発法人理化学研究所, 開拓研究本部, 研究員 (50182994)
|
Co-Investigator(Kenkyū-buntansha) |
BAI LANLAN 国立研究開発法人理化学研究所, 開拓研究本部, 外国人特別研究員
|
Project Period (FY) |
2016-10-07 – 2019-03-31
|
Project Status |
Completed (Fiscal Year 2018)
|
Budget Amount *help |
¥2,200,000 (Direct Cost: ¥2,200,000)
Fiscal Year 2018: ¥500,000 (Direct Cost: ¥500,000)
Fiscal Year 2017: ¥1,100,000 (Direct Cost: ¥1,100,000)
Fiscal Year 2016: ¥600,000 (Direct Cost: ¥600,000)
|
Keywords | Bovine leukemia virus / Receptor for BLV / CAT1/SLC7A1 / Receptor binding domain / Large syncytia / CHO-K1 cells / Envelope glycoprotein (Env) / bovine leukemia virus / CAT1/SLC7a1 / BLV receptor / common B cell epitope / receptor binding domain / BLV / KU-1 / expression library / CDM8 vector |
Outline of Annual Research Achievements |
CAT1/SLC7A1 has been identified as a candidate receptor for bovine leukemia virus (BLV), but whether it is actual receptor remains unknown. BLV binds to cellular receptors on target cells, its membrane fusion is activated, and the virus enters the host cells. The CHO-K1 cells do not express detectable CAT1/SLC7A1 protein and resistant to BLV infection. Therefore, I amplified the CAT1/SLC7A1 gene from cDNA of CD5+ B cell of natural host of BLV and inserted into mammalian expression vector. The large syncytia were detected in CAT1/SLC7A1 transfected CHO-K1 cells that were co-cultured with permanently BLV-infected FLK-BLV cells or the culture supernatant of FLK-BLV cells. These results clearly indicated that bovine CAT1/SLC7A1 expression in resistant CHO-K1 cells conferred susceptible to BLV infection. Next, to further determine whether CAT1/SLC7A1 acted as a cell surface receptor for BLV infection, we verified that BLV particles bound to CAT1/SLC7A1 using flow cytometry. The result showed that CAT1/SLC7A1 functioned as a BLV attachment receptor. Third, for determining CAT1/SLC7A1 binding domain, the common B cell epitope was amplified and inserted into Escherichia coli expression vector pGEX that GST-tag was replace with His-tag to express and purified the fusion protein. I tried to determine CAT1/SLC7A1 binding domain using common B cell epitope fusion protein by pull down and neutralization assay.
|
Research Progress Status |
平成30年度が最終年度であるため、記入しない。
|
Strategy for Future Research Activity |
平成30年度が最終年度であるため、記入しない。
|
Report
(3 results)
Research Products
(27 results)
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
[Presentation] A Vaccine Targeting Bovine Leukemia Virus Susceptible Cattle Suppresses Proviral Load2017
Author(s)
Yoko Aida, Lanlan Bai, Jiyun Kim, Pan He, Yuki Matsumoto, Noriaki Okimoto, Junya Yamagishi, Seiichi Tada, Yoshihiro Ito, Junko Kohara, Shin-nosuke Takeshima
Organizer
18th International Conference on Human Retrovirology HTLV and Related Viruses
Related Report
-
[Presentation] Development of a bovine leukemia virus-like particle vaccine and its immunogenicity in mice and cattle2017
Author(s)
Hiroyuki Otsuke, Saeki Negishi, LanLan Bai, Hirotaka Sato, Shin-nosuke Takeshima, Yoshitaka Imaizumi, Yasuko Nagai, Atsushi Iwamoto, Taichi Noro, Satoshi Sakamoto, Yuki Yamaguchi, Hiroshi Handa, Eiji Oishi,Yoko Aida
Organizer
18th International Conference on Human Retrovirology HTLV and Related Viruses
Related Report
-